Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Clinical trial NCT06090318 · WITHDRAWN

Trial details

NCT number: NCT06090318
Sponsor: Rain Oncology Inc
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor CDKN2A NSCLC Urothelial Carcinoma Bladder Melanoma Pancreas Adenocarcinoma HNSCC Renal Cell Carcinoma Mesothelioma Gastric Cancer

Start date: 2023-05-19
Primary completion: 2023-05-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.